Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Anthrax vaccine adsorbed adjuvanted - Emergent BioSolutions

Next Previous
Search
Drug Profile

Anthrax vaccine adsorbed adjuvanted - Emergent BioSolutions

Alternative Names: AV 7909; AV7909 Anthrax Vaccine Adsorbed; BioThrax + agatolimod; CYFENDUS; NuThrax; Third-generation anthrax vaccine candidate (BioThrax + CPG 7909) - Emergent BioSolutions

Latest Information Update: 08 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Emergent BioSolutions
  • Developer Biomedical Advanced Research and Development Authority; Emergent BioSolutions
  • Class Anthrax vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Anthrax
  • New Molecular Entity No

Highest Development Phases

  • Registered Anthrax

Most Recent Events

  • 02 Jul 2024 Emergent Biosolutions receives BARDA contract valued at $US30.0 million for AV 7909
  • 11 Oct 2023 Immunogenicity and adverse events data from a phase III trial in Anthrax presented at the IDWeek 2023 (IDW-2023)
  • 11 Oct 2023 Immunogenicity, pharmacokinetics and adverse events data from a phase II Velocity 2 trial in Anthrax (In Volunteers, Combination therapy, Prevention) presented at the IDWeek 2023 (IDW-2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top